July 31, 2002 - Launch of women's healthcare products portfolio expected within third quarter 2002

July 18, 2002 - Partnership maximizes initial sales and marketing support for potential new antidepressant.

April 15, 2002 - Companies sign letter of intent to form drug development venture

March 22, 2002 - Quintiles Transnational Corp. today announced that it has acquired certain assets of Bioglan Pharma Inc., the U.S. subsidiary of U.K.-based Bioglan Pharma Plc, in a transaction valued at approximately $26.7 million (18.5 million pounds).

January 30, 2002 - Quintiles Transnational Corp. today announced the signing of an agreement with Kos Pharmaceuticals, Inc. to commercialize Advicor® and Niaspan® in the United States for the treatment of cholesterol disorders.